Barclay analysts raise SCA price target to $45 — 5 notes

Surgical Care Affiliates had its price target raised from $42.00 to $45.00 by analysts at Barclays, according to WKRB.

Advertisement

 Here are five facts:

1. SCA presently has an overweight rating on the stock.

2.  SCA stock has an average rating of “Hold.”

3. The company has an average target price of $40.13.

4. General Counsel Richard L. Jr. Sharff sold 44,140 shares of SCA stock for a total transaction of $1.7 million.

5. SCA shares traded down 6.12 percent on Wednesday, reaching $36.23.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.